Yasunori Tawaragi

Title: Yasunori Tawaragi: Innovator in C-Type Natriuretic Peptide Research

Introduction

Yasunori Tawaragi is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of biotechnology, particularly in the study of C-type natriuretic peptides (CNP). With a total of 3 patents, Tawaragi's work has implications for medical research and therapeutic applications.

Latest Patents

Tawaragi's latest patents include groundbreaking research on the human CNP gene and its precursor protein. This patent details the gene of human CNP, as well as the hCNP precursor protein encoded by this gene. The amino acid sequence of the hCNP precursor is also represented in the patent documentation. Another significant patent involves the porcine CNP gene and precursor protein. This patent discloses the gene and cDNA of a porcine-derived CNP, along with its precursor protein and derivatives. The amino acid sequence of the porcine derivative CNP precursor is also included in this patent.

Career Highlights

Throughout his career, Tawaragi has worked with prominent companies, including Suntory Limited. His research has contributed to advancements in understanding natriuretic peptides, which play a crucial role in cardiovascular health.

Collaborations

Tawaragi has collaborated with esteemed colleagues such as Hisayuki Matsuo and Shoji Tanaka. These collaborations have further enriched his research and innovation in the field.

Conclusion

Yasunori Tawaragi's contributions to the study of C-type natriuretic peptides have established him as a key figure in biotechnology. His patents reflect a commitment to advancing medical science and improving health outcomes.